Menu
← Oncology Approval Tracker
FDA DECISION ·
Datroway
datopotamab deruxtecan-dlnk · Daiichi Sankyo
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
For adults with unresectable or metastatic HR-positive, HER2-negative breast cancer after endocrine-based treatment and chemotherapy for that advanced disease.
LAMPGEN ANALYSIS
Why it matters
The first Datroway approval introduced a TROP2-directed antibody–drug conjugate after endocrine therapy and chemotherapy.
What research teams should watch
Plan oral and ocular supportive measures and give patients a route to report early signs of pneumonitis.
PRIMARY RECORDS